Latest News & Features
Americas
Forest Laboratories, a subsidiary of Allergan, has taken on Mylan over a generic version of a constipation drug. 3 April 2018
Asia-Pacific
Eisai has partnered with fellow Japanese pharmaceutical company Nichi-Iko Pharmaceutical to expand and grow Nichi-Iko’s generic business. 3 April 2018
Asia-Pacific
Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire. 3 April 2018
Americas
The US Court of Appeals for the Federal Circuit has ordered the Patent and Trial Appeal Board to halt its review of patents covering a dry eye medication while the court considers arguments that tribal immunity protects the patents from board proceedings. 29 March 2018
Biotechnology
The English Court of Appeal has reversed a finding that two of Regeneron’s European patents covering transgenic mice were insufficient. 29 March 2018
Americas
A US judge has overturned a jury verdict which found that Teva owed GSK $235 million in damages for infringing a patent covering a blood pressure drug. 29 March 2018
Americas
A Delaware court has dismissed a patent infringement claim brought by Amgen against a biosimilar maker. 28 March 2018
Big Pharma
GSK has revealed that it will buy Novartis out of their joint consumer healthcare business. 27 March 2018
Americas
A US judge handed a win to Shire late last week, finding that a generic version of its attention deficit hyperactivity disorder drug Adderall XR would infringe Shire’s patents. 27 March 2018
Europe
The English High Court has rejected molecular diagnostics company Premaitha Health’s attempt to stop a patent infringement claim. 26 March 2018